We thank Dr Dariush Nikkhah and his co-authors for their interest in our article entitled ‘Classification of Raynaud’s disease based on angiographic features’.
1They have suggested including botulinum therapy in the treatment algorithm for chronic intractable ischaemic digits resulting from Raynaud’s disease.
- Kim Y.H.
- Ng S.W.
- Seo H.S.
- Chang Ahn H.
Classification of Raynaud’s disease based on angiographic features.
J Plast Reconstruct Aesthet Surg. 2011; 64: 1503-1511
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Classification of Raynaud’s disease based on angiographic features.J Plast Reconstruct Aesthet Surg. 2011; 64: 1503-1511
- Botulinum toxin in the treatment of Raynaud’s phenomenon: a pilot study.Eur J Clin Invest. 2004; 34: 312
- Management of vasospastic disorders with botulinum toxin A.Plast Reconstr Surg. 2007; 119: 217
- Botox therapy for ischemic digits.Plast Reconstr Surg. 2009; 124: 191-201
- Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud’s phenomenon.J Hand Surg Am. 2009; 2009: 446-452
Published online: February 16, 2012
© 2012 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Inc. All rights reserved.
ScienceDirectAccess this article on ScienceDirect
- Rationalising treatment of Raynaud’s syndromeJournal of Plastic, Reconstructive & Aesthetic SurgeryVol. 65Issue 7
- PreviewWe read with great interest the article entitled ‘Classification of Raynaud’s disease based on angiographic features.’1 We congratulate the authors for attempting to rationalise their previous surgical practice in managing digital ischaemia in the hand into a treatment-oriented classification. Whilst we believe that this approach may improve the treatment of patients with symptoms refractory to medical measures, we believe that the algorithm is incomplete, and not adequately justified.